Clinical Trials Logo

Cervical Cancer, Stage IIB clinical trials

View clinical trials related to Cervical Cancer, Stage IIB.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05736315 Completed - Clinical trials for Cervical Cancer, Stage IIB

Use of a Fermented Dairy Beverage in Cervical Cancer Patients Undergoing Concurrent Chemoradiation Therapy

Start date: April 25, 2005
Phase: N/A
Study type: Interventional

Many cancer survivors have increased risk of intestinal damage, affecting the quality of life of patients. The role of intestinal microbiota on the development of gastrointestinal toxicity and radiation enteritis has been described in cervical cancer patients that received pelvic RT. In this project we investigated the effect that a fermented dairy beverage (Yakult) may have in the modulation of inflammation and consequently of gastrointestinal toxicity in locally advanced cervical cancer (LACC) patients treated with concomitant chemo-radiotherapy (CRT).